Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Achieve Life Sciences Inc
(NQ:
ACHV
)
9.750
USD
+0.660 (+7.26%)
Official Closing Price
Updated: 7:59 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Achieve Life Sciences Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference
January 07, 2021
From
ACCESSWIRE
Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option
December 07, 2020
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine...
From
PR Newswire
70 Biggest Movers From Yesterday
December 04, 2020
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 150% to close at $5.25 on Thursday after gaining 7% on ...
Tags
EXPR
PRTH
GES
From
Benzinga
54 Stocks Moving In Thursday's Mid-Day Session
December 03, 2020
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares jumped 150% to $5.25 after gaining 7% on Wednesday. The company ...
Tags
Top Gainers
HIBB
DTIL
From
Benzinga
Achieve Life Sciences Announces Pricing of $15 Million Public Offering
December 03, 2020
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine...
From
PR Newswire
38 Stocks Moving in Thursday's Pre-Market Session
December 03, 2020
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) rose 95.2% to $4.10 in pre-market trading after gaining 7% on ...
Tags
ITRM
ORMP
LGVW
From
Benzinga
12 Healthcare Stocks Moving In Monday's Pre-Market Session
November 30, 2020
Gainers Sunesis Pharmaceuticals (NASDAQ:SNSS) stock rose 50.0% to $2.25 during Monday's pre-market session. The ...
Tags
Benzinga
BIOL
Top Gainers
From
Benzinga
Achieve Life Sciences Announces Proposed Public Offering
November 30, 2020
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine...
From
PR Newswire
Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update
November 12, 2020
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine...
From
PR Newswire
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
November 12, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
BIOC
IBB
SLGL
From
Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
November 08, 2020
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ...
Tags
VIVO
Penny Stocks
RETA
From
Benzinga
Achieve Life Sciences to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020
October 29, 2020
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine...
From
PR Newswire
Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual Roundtable on November 17th, 2020
October 27, 2020
From
PR Newswire
Achieve Life Sciences Announces to Present at the MicroCap Best Ideas Conference, October 13, 2020
October 08, 2020
From
ACCESSWIRE
Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline for Smoking Cessation
October 07, 2020
Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compared to Placebo
From
PR Newswire
Achieve Life Sciences Announces Appointment of John Bencich to Chief Executive Officer & Dr. Cindy Jacobs to President
September 30, 2020
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced the...
From
PR Newswire
4 Sectors Moving Down In Friday's Pre-Market Session
September 25, 2020
Here is the sector-by-sector list of stocks moving lower in today's pre-market session: Healthcare EyePoint ...
Tags
NNDM
NAOV
Trading Ideas
From
Benzinga
Achieve Announces Presentation of Investigator-Led RAUORA Trial Data Demonstrating Significantly Fewer Side Effects with Higher Quit Rates for Cytisinicline (cytisine) Compared to Chantix® (vareniclin
September 18, 2020
Subjects in the Cytisinicline Arm Were 55% More Likely to Quit Smoking at 6 Months Compared to Subjects Who Received Varenicline
From
PR Newswire
The Daily Biotech Pulse: Roche's COVID Combo Therapy Reduces Need For Ventilation, ESMO Presentations
September 18, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ALKS
Top Stories
PFE
From
Benzinga
Achieve Life Sciences Announces Results from Evaluation of Cytisinicline (cytisine) versus Chantix® (varenicline) in 5-HT3 Receptor Binding Assay Study
September 18, 2020
Provides Mechanistic Rationale for the Clinical Findings that Cytisinicline (Cytisine) Treatment is Associated with Lower Rates of Nausea and Vomiting compared to Chantix
From
PR Newswire
Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 20th Annual Society for Research on Nicotine & Tobacco Europe (SRNT-E) Virtual Conference
September 10, 2020
Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced...
From
PR Newswire
Achieve Life Sciences to Present at Upcoming Investor Conferences
September 03, 2020
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced...
From
PR Newswire
Achieve Reports Financial Results for Second Quarter 2020 and Provides Update on Cytisinicline Development Program
August 06, 2020
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine...
From
PR Newswire
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
August 06, 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) ABIOMED, Inc. (NASDAQ: ABMD) Aerpio Pharmaceuticals Inc ...
Tags
BFRA
PFNX
EDIT
From
Benzinga
84 Biggest Movers From Yesterday
August 05, 2020
Gainers Alterity Therapeutics Limited (NASDAQ: ATHE) shares climbed 154.1% to close at $3.43 on Tuesday after the company said ...
Tags
OIIM
BTN
Movers From Yesterday
From
Benzinga
70 Stocks Moving In Tuesday's Mid-Day Session
August 04, 2020
Gainers Alterity Therapeutics Limited (NASDAQ: ATHE) shares jumped 255.6% to $4.80 said new data from an experiment testingits ...
Tags
VRNS
STRL
ATCX
From
Benzinga
Achieve Life Sciences Announces Pricing of $6.5 Million Public Offering
August 04, 2020
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine...
From
PR Newswire
The Daily Biotech Pulse: Voyager, AbbVie End Collaboration, Thumbs Down For DBV's Peanut Allergy Patch, Tiziana Expedites COVID-19 Trial Plans
August 04, 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) ABIOMED, Inc. (NASDAQ: ABMD) ALX Oncology Holdings Inc ...
Tags
XNCR
QDEL
MNK
From
Benzinga
46 Stocks Moving in Tuesday's Pre-Market Session
August 04, 2020
Gainers Alterity Therapeutics Limited (NASDAQ: ATHE) shares rose 229% to $4.44 in pre-market trading after the company announced ...
Tags
Top Gainers
SEDG
Markets
From
Benzinga
8 Stocks To Watch For August 4, 2020
August 04, 2020
Some of the stocks that may grab investor focus today are: Wall Street expects Exelon Corporation (NYSE: EXC) to report quarterly ...
Tags
Trading Ideas
Earnings
DIS
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.